v3.26.1
Stockholders' Equity
 6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ Equity
Issuance of Common Stock
On November 20, 2025, the Company filed with the SEC, and amended on December 15, 2025, a registration statement on Form S-4. This registration statement was declared effective by the SEC on December 18, 2025 and registered the Company’s offer of up to 45,000 shares of the Company’s common stock in connection with the Merger (as defined in “Note 2—Acquisition of Astria Therapeutics, Inc.” herein).
On January 23, 2026, the Company issued 37,282 shares of common stock to Astria’s equity holders in connection with the Merger (see “Note 2—Acquisition of Astria Therapeutics, Inc.”).
Shares Reserved for Future Issuance of Common Stock
The Company had reserved shares of common stock for issuance as follows:
June 30, 2026December 31, 2025
Shares reserved for exercises of outstanding stock options36,916 43,344 
Shares reserved for vesting of restricted stock units12,403 12,166 
Shares reserved for future issuance under the Stock Incentive Plan15,759 6,852 
Shares reserved for future issuance under the Inducement Equity Incentive Plan 1,020 1,460 
Shares reserved for future issuance under the Employee Stock Purchase Plan4,475 4,674 
Total shares reserved for future issuance70,573 68,496